Cellular targets of 3′-azido-3′-deoxythymidine: an early (non-delayed) effect on oxidative phosphorylation

This publication has 15 references indexed in Scilit:

• Mechanisms of toxicity of 3′-azido-3′- deoxythymidine: Its interaction with adenylate kinase
  Biochemical Pharmacology, 1994
• Cardiac mitochondrial DNA polymerase-gamma is inhibited competitively and noncompetitively by phosphorylated zidovudine.
  Circulation Research, 1994
• Ultrastructural changes associated with reduced mitochondrial DNA and impaired mitochondrial function in the presence of 2'3'-dideoxycytidine
  Antimicrobial Agents and Chemotherapy, 1992
• The friend murine erythroleukemia cell, a model system for studying the association between bone marrow toxicity induced by 3'-azido-3'-dideoxythymidine and dideoxynucleoside inhibition of mtDNA replication
  Biochemical Pharmacology, 1992
• The 5′-triphosphates of 3′-azido-3′-deoxythymidine and 2′, 3′-dideoxynucleosides inhibit DNA polymerase γ by different mechanisms
  Biochemical and Biophysical Research Communications, 1991
• The pc12 cell as a model for studies of the mechanism of induction of peripheral neuropathy by anti-HIV-1 dideoxynucleoside analogs
  Biochemical Pharmacology, 1991
• Massive conversion of guanosine to 8-hydroxy-guanosine in mouse liver mitochondrial DNA by administration of azidothymidine
  Biochemical and Biophysical Research Communications, 1991
• Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy
  The Lancet, 1991
• Mitochondrial Myopathy Caused by Long-Term Zidovudine Therapy
  New England Journal of Medicine, 1990
• Studies on the inhibition of mitochondrial DNA replication by 3′-azido-3′-dhoxythymidine and other dideoxynucleoside analogs which inhibit HIV-1 replication
  Biochemical Pharmacology, 1989